Search Tag: SARS-CoV-2
2022 04 Oct
A three-year project, known as END-VOC, will analyse data from 28 established cohort studies in 23 countries, collaborating with 19 partners across the world. This large-scale study, funded by the European Commission, and led by UCL, aims to collect this data to better detect and improve understanding of emerging SARS-CoV-2 variants. The purpose is...Read more
2022 13 Jan
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha and Gamma variants following third dose booster with Vaxzevria Additional analysis showed increased antibody response to Omicron after a third dose Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial...Read more
2020 13 Oct
Johnson & Johnson has announced temporarily pausing the COVID-19 vaccine candidate trials due to an unexplained illness in a study participant. You might also like: Rushing COVID-19 Vaccine Development: Is It Justified? As reported by STAT News, the company has informed external researchers through a document that a “passing...Read more
2020 24 Sep
New research from the UK has detected SARS-CoV-2 seroconversion among asymptomatic healthcare workers. Moreover, researchers were able to identify variation in the occupational risk of exposure to the pathogen – which causes COVID-19 – between hospital departments. You might also like: COVID-19: Risk Factors for Healthcare Workers...Read more
2020 15 Sep
The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level...Read more
2020 15 Sep
The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level...Read more
2020 06 Aug
Widespread testing for COVID-19 derives important epidemiological data that can inform strategies on disease monitoring and control. However, shortages of test kits and bottlenecks in processing of results prevent many countries from implementing mass testing. This leaves many patients (especially those not showing symptoms) untested, increasing...Read more
2020 20 Apr
Sir Andrew Witty, president of UnitedHealth Group and CEO of Optum and f ormer GlaxoSmithKline (GSK) chief executive , has taken a leave of absence from his current job to join the World Health Organization (WHO) in the agency’s efforts to develop a COVID-19 vaccine. You may also like: Where Does COVID-19 Vaccine Development Stand?...Read more
2020 16 Apr
A new study published in the Annals of Internal Medicine assesses challenges faced by general practitioners (GPs) in the prevention and management of COVID-19 in Lombardy, Italy. You may also like : COVID-19 Pandemic: Lessons from Italy As of 8 April, Italy was the most COVID-19-affected country in Europe. Of 135 000...Read more
2020 16 Apr
Researchers use mathematical modelling to predict the persistence of SARS-CoV-2 in the human population after its initial pandemic stage and compute a more realistic picture of the coronavirus infection rate . You may also like : Where Does COVID-19 Vaccine Development Stand? Five-Year Projection One study (...Read more
2020 11 Apr
Researchers around the world are testing a wide range of COVID-19 vaccine candidates, with over a hundred vaccines in development, and almost 600 clinical trials either ongoing or completed. You may also like : Teaming and Funding Opportunities for COVID-19 Researchers The Coalition for Epidemic Preparedness Innovations (CEPI),...Read more
2020 09 Apr
An early-released review warns about potentially serious adverse events for chloroquine, hydroxychloroquine and azithromycin when used to treat and prevent COVID-19 . It comes only days after the U.S. Centers for Disease Control and Prevention (CDC) had removed guidelines for using hydroxychloroquine as a potential treatment. ...Read more
2020 27 Mar
The majority of countries have introduced at least some nation-wide measures aimed at containing the spread of the novel coronavirus pandemic. The measures include stopping/limiting international and domestic movement, closing educational facilities, banning public gatherings or announcing quarantine, to name a few. You may...Read more
2020 22 Mar
The German Society of Infectious Diseases ( DGI ) has initiated the establishment of a European case registry to collect clinical data of patients with SARS-CoV-2 infection. You may also like: Germany Joins ‘1+ Million Genomes’ Initiative The new registry, Lean European Open Survey for SARS-CoV-2 Infected Patients...Read more